跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,653 条关于
“PI3K-Akt”
全部
6,653
临床试验
3,868
药物
650
机构
77
资讯
2,058
去年
Faeth Therapeutics Advances Novel Three-Pronged Approach for Metabolism-Driven Cancers with Promising Preclinical Results
4个月前
Real-World Study Reveals Lower Hyperglycemia Management Burden with Capivasertib Versus Alpelisib in Metastatic Breast Cancer
7个月前
Totus Medicines to Present Updated Phase 1 Data for Novel Covalent PI3Kα Inhibitor TOS-358 at ESMO TAT Congress
上个月
Advanced Endometrial Cancer Pipeline Gains Momentum as ADCs, Immunotherapy and Targeted Combinations Reshape Treatment
去年
Cosmos Health Acquires Rights to Two Patented Anticancer Drugs Targeting Multiple Cancers
9个月前
Tumor-Associated Macrophages Drive Gastric Cancer Progression Through Immune Evasion and Therapeutic Resistance
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
11个月前
Faeth Therapeutics Raises $25M to Advance PIKTOR Therapy After 80% Response Rate in Endometrial Cancer
去年
Gedatolisib Shows Promising 77-Month Overall Survival in Advanced Breast Cancer Phase 1b Trial
11个月前
Faeth Therapeutics Reports Positive Phase 2 Results for Sapanisertib in Ovarian Cancer Treatment
第 1 页,共 206 页
上一页
下一页